nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A Novel Biological Strategy for Myocardial Protection by Intracoronary Delivery of Mitochondria: Safety and Efficacy
|
Shin, Borami |
|
|
|
8 |
p. 871-888 |
artikel |
2 |
A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy Participants
|
Malik, Fady I. |
|
|
|
8 |
p. 763-775 |
artikel |
3 |
Associations of Interleukin-5 With Plaque Development and Cardiovascular Events
|
Knutsson, Anki |
|
|
|
8 |
p. 891-902 |
artikel |
4 |
Autosis
|
Nah, Jihoon |
|
|
|
8 |
p. 857-869 |
artikel |
5 |
Beta1-Adrenergic Receptor Cleavage and Regulation by Elastase
|
Zhu, Jing |
|
|
|
8 |
p. 976-988 |
artikel |
6 |
Cardiac Lymphatic Insufficiency Leads to Diastolic Dysfunction Via Myocardial Morphologic Change
|
Pu, Zhongyue |
|
|
|
8 |
p. 958-972 |
artikel |
7 |
Cardiac Sympathetic-Parasympathetic Interaction
|
Dusi, Veronica |
|
|
|
8 |
p. 811-814 |
artikel |
8 |
Cardiac Versus Renal Response to Volume Expansion in Preclinical Systolic Dysfunction With PDEV Inhibition and BNP
|
Wan, Siu-Hin |
|
|
|
8 |
p. 962-972 |
artikel |
9 |
Cardio-Oncology
|
Karlstaedt, Anja |
|
|
|
8 |
p. 705-718 |
artikel |
10 |
Cat-apulting Toward a Molecular Understanding of HFpEF ∗
|
Robinson, Emma L. |
|
|
|
8 |
p. 673-675 |
artikel |
11 |
CFTR Therapeutics Normalize Cerebral Perfusion Deficits in Mouse Models of Heart Failure and Subarachnoid Hemorrhage
|
Lidington, Darcy |
|
|
|
8 |
p. 940-958 |
artikel |
12 |
Circulating Hepatocyte Growth Factor Reflects Activation of Vascular Repair in Response to Stress
|
Chen, Yihong |
|
|
|
8 |
p. 747-762 |
artikel |
13 |
Circulating Progenitor Cells in Patients With Coronary Artery Disease and Renal Insufficiency
|
Mehta, Anurag |
|
|
|
8 |
p. 770-782 |
artikel |
14 |
Circulating Progenitor Cells Predict Clinical Outcomes in Patients With Coronary Artery Disease and Renal Insufficiency ∗
|
Vlachogiannis, Nikolaos I. |
|
|
|
8 |
p. 783-785 |
artikel |
15 |
Clec4e-Receptor Signaling in Myocardial Repair After Ischemia-Reperfusion Injury
|
Veltman, Denise |
|
|
|
8 |
p. 631-646 |
artikel |
16 |
Clinical Phenotypes of Heart Failure With Preserved Ejection Fraction to Select Preclinical Animal Models
|
van Ham, Willem B. |
|
|
|
8 |
p. 844-857 |
artikel |
17 |
Correction
|
|
|
|
|
8 |
p. 994 |
artikel |
18 |
Development of Tissue Engineered Heart Valves for Percutaneous Transcatheter Delivery in a Fetal Ovine Model
|
Zakko, Jason |
|
|
|
8 |
p. 815-828 |
artikel |
19 |
Dissecting Beta-Adrenergic Receptors
|
Port, J. David |
|
|
|
8 |
p. 989-991 |
artikel |
20 |
Editorial Board
|
|
|
|
|
8 |
p. A1-A3 |
artikel |
21 |
Editorial Board
|
|
|
|
|
8 |
p. A1-A3 |
artikel |
22 |
Editorial Board
|
|
|
|
|
8 |
p. A1-A3 |
artikel |
23 |
Editorial Board
|
|
|
|
|
8 |
p. A1-A3 |
artikel |
24 |
Epigenetics in Cardiac Hypertrophy and Heart Failure
|
Liu, Chia-Feng |
|
|
|
8 |
p. 976-993 |
artikel |
25 |
Extracellular Matrix Biomaterial Therapy for Myocardial Infarction
|
Christman, Karen L. |
|
|
|
8 |
p. 955-957 |
artikel |
26 |
Focusing on the Native Matrix Proteins in Calcific Aortic Valve Stenosis
|
Anousakis-Vlachochristou, Nikolaos |
|
|
|
8 |
p. 1028-1039 |
artikel |
27 |
Full Issue PDF
|
|
|
|
|
8 |
p. I-LXXXVIII |
artikel |
28 |
Full Issue PDF
|
|
|
|
|
8 |
p. I-CXVIII |
artikel |
29 |
Full Issue PDF
|
|
|
|
|
8 |
p. B1-B127 |
artikel |
30 |
Full Issue PDF
|
|
|
|
|
8 |
p. I-CXLIX |
artikel |
31 |
Full Issue Pdf
|
|
|
|
|
8 |
p. I-CXIV |
artikel |
32 |
GLP-1 Receptor Agonists, the Holy Grail Preventing Atrial Fibrillation in Patients With T2D? ∗
|
Stoll, Lisa |
|
|
|
8 |
p. 937-938 |
artikel |
33 |
Glucagon-Like Peptide-1 Protects Against Atrial Fibrillation and Atrial Remodeling in Type 2 Diabetic Mice
|
Bohne, Loryn J. |
|
|
|
8 |
p. 922-936 |
artikel |
34 |
Glycation and Infiltration of Serum Albumin
|
Côté, Nancy |
|
|
|
8 |
p. 767-769 |
artikel |
35 |
Glycation and Serum Albumin Infiltration Contribute to the Structural Degeneration of Bioprosthetic Heart Valves
|
Frasca, Antonio |
|
|
|
8 |
p. 755-766 |
artikel |
36 |
Heart Failure in Humans Reduces Contractile Force in Myocardium From Both Ventricles
|
Blair, Cheavar A. |
|
|
|
8 |
p. 786-798 |
artikel |
37 |
High-Throughput Microscopy Characterization of Rare LDLR Variants
|
Graça, Rafael |
|
|
|
8 |
p. 1010-1021 |
artikel |
38 |
IFN-γ-STAT1-ERK Pathway Mediates Protective Effects of Invariant Natural Killer T Cells Against Doxorubicin-Induced Cardiomyocyte Death
|
Sada, Masashi |
|
|
|
8 |
p. 992-1007 |
artikel |
39 |
INKing the Cardiotoxicity Out of Doxorubicin ∗
|
Guo, Zhen |
|
|
|
8 |
p. 1008-1009 |
artikel |
40 |
Instructions for Authors
|
|
|
|
|
8 |
p. A4-A13 |
artikel |
41 |
Interleukin 5 Contributes to Human Atherosclerosis Development But not to Thrombotic Complications ∗
|
Ait-Oufella, Hafid |
|
|
|
8 |
p. 903-904 |
artikel |
42 |
Iron Overload via Heme Degradation in the Endoplasmic Reticulum Triggers Ferroptosis in Myocardial Ischemia-Reperfusion Injury
|
Miyamoto, Hiroko Deguchi |
|
|
|
8 |
p. 800-819 |
artikel |
43 |
Large Animal Models of Heart Failure
|
Silva, Kleiton Augusto Santos |
|
|
|
8 |
p. 840-856 |
artikel |
44 |
Leveraging FPR2 Agonists to Resolve Inflammation and Improve Outcomes Following Myocardial Infarction ∗
|
Koenig, Andrew L. |
|
|
|
8 |
p. 690-692 |
artikel |
45 |
Macrophage Polarization as a Novel Therapeutic Target for Endovascular Intervention in Peripheral Artery Disease
|
Tan, Richard P. |
|
|
|
8 |
p. 693-704 |
artikel |
46 |
Micronized Acellular Matrix Biomaterial Leverages Eosinophils for Postinfarct Cardiac Repair
|
Vasanthan, Vishnu |
|
|
|
8 |
p. 939-954 |
artikel |
47 |
Minimally Invasive Delivery of Tissue Engineered Heart Valves to the Pulmonary Annulus ∗
|
Roche, Ellen T. |
|
|
|
8 |
p. 829-830 |
artikel |
48 |
Mitochondrial DNA in Uremia and New Targets to Treat Myocardial Hypertrophy in the Cardiorenal Syndrome ∗
|
Bayliss, George |
|
|
|
8 |
p. 841-843 |
artikel |
49 |
Moderating the Myosin Motor to Treat Hypertrophic Cardiomyopathy ∗
|
Papp, Zoltán |
|
|
|
8 |
p. 776-778 |
artikel |
50 |
Molecular Signature of HFpEF
|
Gibb, Andrew A. |
|
|
|
8 |
p. 650-672 |
artikel |
51 |
Optogenetic Stimulation of Vagal Efferent Activity Preserves Left Ventricular Function in Experimental Heart Failure
|
Machhada, Asif |
|
|
|
8 |
p. 799-810 |
artikel |
52 |
Paradoxical Cardiorenal Responses Following Acute Vasodilator/Natriuretic Treatment in Presystolic Heart Failure
|
Polonsky, Tamar S. |
|
|
|
8 |
p. 973-975 |
artikel |
53 |
Parkin Controls Cardiac Function in Obesity by Regulating Mitochondrial Calcium Uptake ∗
|
Jankauskas, Stanislovas |
|
|
|
8 |
p. 797-799 |
artikel |
54 |
Parkin Insufficiency Accentuates High-Fat Diet–Induced Cardiac Remodeling and Contractile Dysfunction Through VDAC1-Mediated Mitochondrial Ca2+ Overload
|
Wu, Ne N. |
|
|
|
8 |
p. 779-796 |
artikel |
55 |
Preservation of Post-Infarction Cardiac Structure and Function via Long-Term Oral Formyl Peptide Receptor Agonist Treatment
|
García, Ricardo A. |
|
|
|
8 |
p. 905-920 |
artikel |
56 |
Sailing the Uncharted Waters of Familial Hypercholesterolemia LDL Receptor Genetic-Related Variants
|
Santos, Raul D. |
|
|
|
8 |
p. 1022-1024 |
artikel |
57 |
Seipin Knockout Mice Develop Heart Failure With Preserved Ejection Fraction
|
Bai, Bo |
|
|
|
8 |
p. 924-937 |
artikel |
58 |
Selective FPR2 Agonism Promotes a Proresolution Macrophage Phenotype and Improves Cardiac Structure-Function Post Myocardial Infarction
|
García, Ricardo A. |
|
|
|
8 |
p. 676-689 |
artikel |
59 |
sGC Stimulation Saves the Diabetic Heart
|
Papapetropoulos, Andreas |
|
|
|
8 |
p. 919-921 |
artikel |
60 |
Stimulation of Erythrocyte Soluble Guanylyl Cyclase Induces cGMP Export and Cardioprotection in Type 2 Diabetes
|
Jiao, Tong |
|
|
|
8 |
p. 907-918 |
artikel |
61 |
Targeted Cardiac Ionizing Radiation in Dahl Salt-Sensitive Rats Can Improve Recovery From Ischemic Injury
|
SenthilKumar, Gopika |
|
|
|
8 |
p. 1025-1027 |
artikel |
62 |
Targeting Muscles in the Brain to Enhance Cerebral Perfusion ∗
|
Lee, Jin-Moo |
|
|
|
8 |
p. 959-961 |
artikel |
63 |
Targeting Myocardial Mitochondria-STING-Polyamine Axis Prevents Cardiac Hypertrophy in Chronic Kidney Disease
|
Han, Wenhao |
|
|
|
8 |
p. 820-840 |
artikel |
64 |
The Bslc2 –/– Mouse
|
Salloum, Fadi N. |
|
|
|
8 |
p. 938-939 |
artikel |
65 |
The New Promise of Mitochondrial Transplantation for Myocardial Recovery ∗
|
Tang, W.H. Wilson |
|
|
|
8 |
p. 889-890 |
artikel |
66 |
Therapeutic Treatment Approaches Post–Myocardial Infarction
|
Zaman, Rysa |
|
|
|
8 |
p. 921-923 |
artikel |
67 |
Unveiling the Impact of Cardiac Lymphatic Pathology on Diastolic Dysfunction and Therapeutic Potential of Lymphangiogenesis ∗
|
Itkin, Maxim |
|
|
|
8 |
p. 973-975 |
artikel |
68 |
Update to Drugs, Devices, and the FDA
|
Van Norman, Gail A. |
|
|
|
8 |
p. 831-839 |
artikel |
69 |
When Sensing Goes Wrong
|
Delgobo, Murilo |
|
|
|
8 |
p. 647-649 |
artikel |
70 |
Who Should Be Accountable for Scientific Accountability?
|
Mann, Douglas L. |
|
|
|
8 |
p. 1040-1042 |
artikel |